Although two new trials failed to show a cancer link for Vytorin, the cholesterol-lowering drug isn't ready to be completely cleared, the editor of the New England Journal of Medicine says.
new england journalNew Debate Over Vytorin and CancerWebMD Health Tue, 09/02/2008 - 12:30
Although two new trials failed to show a cancer link for Vytorin, the cholesterol-lowering drug isn't ready to be completely cleared, the editor of the New England Journal of Medicine says. Tags:
National study shows magensium sulfate reduces risk of cerebral ...EurekAlert! - Medicine and Health Thu, 08/28/2008 - 23:00
(Northwestern Memorial Hospital) Results of a 10-year study published in the August 28 issue of the New England Journal of Medicine found that magnesium sulfate administered to women delivering before 32 weeks of gestation reduced the risk of cerebral palsy by 50 percent. Tags:
NIAID describes challenges, prospects for an HIV vaccineEurekAlert! - Infectious and Emerging Diseases Tue, 08/26/2008 - 23:00
(NIH/National Institute of Allergy and Infectious Diseases) Events of the past year in HIV vaccine research have led some to question whether an effective HIV vaccine will ever be developed. Tags:
More Questions About Conflicts of Interest and "Surviving Sepsis...Health Care Renewal Sat, 08/16/2008 - 16:04
Two years ago, we posted about questions whether the "Surviving Sepsis" campaign was driven by marketing as well as science. Tags:
Organ donation after cardiac deathEurekAlert! - Medicine and Health Wed, 08/13/2008 - 23:00
(University of Pennsylvania School of Medicine) The Aug. 14 issue of the New England Journal of Medicine explores the issue of organ donation after cardiac death. Tags:
What Influences Advocates of Providing "More, Not Less, Truthful...Health Care Renewal Mon, 08/04/2008 - 14:35
Last week's New England Journal of Medicine included a letter [Troy DE, Gottlieb S. Tags:
Attacking "Side Effects" with Logical Fallacies, Version 2Health Care Renewal Thu, 07/24/2008 - 09:59
Side Effects by Alison Bass continues to generate controversy. used the case of Paxil to expose the unsavory and self-serving relationships among members of the pharmaceutical industry, psychiatrists, and members of the FDA. The reviewer concluded, Tags:
War Deaths Spark Controversy in NEJMMedPage Today Infectious Disease Wed, 07/23/2008 - 16:23
BALTIMORE -- The Iraq war has ignited a feud within a small group known as war epidemiologists and the battleground is the New England Journal of Medicine. Tags:
Attacking "Side Effects" with Logical FallaciesHealth Care Renewal Fri, 07/18/2008 - 12:05
Concerns about manipulation and suppression of the clinical research literature are gaining more traction. Recently, Alison Bass published Side Effects, a book that explored one of the more vivid cases.
The reviewer concluded, Tags:
Journal Editors Take Aim at Supreme Court for Gun-Control RulingMedPage Today Infectious Disease Wed, 07/09/2008 - 16:00
BOSTON -- The landmark Supreme Court decision that struck down the District of Columbia's ban on handguns "has launched the country on a risky epidemiologic experiment," according to the editors of the New England Journal of Medicine. Tags:
|